Article

Allelic Variants in the Warfarin-related Genes VKORC1 and CYP2C9 in a Western Saudi Population

Amina M. Bagher1★, Wedyan S. Alharbi2, Lamees S. Gadi2, Lenah S. Binmahfouz1, Rawan H Hareeri1★ Corresponding author

  1. 1Department of Pharmacology and Toxicology, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia.
  2. 2Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia.

CORRESPONDENCE

Amina M. Bagher

Department of Pharmacology and Toxicology, King Abdulaziz University Jeddah, Makkah 21589, Saudi Arabia.

abagher@kau.edu.sa

Received: 06-04-2023; Revised: 10-06-2023; Accepted: 12-06-2023.

Volume 14, Issue 2 · pp. 125–132 · PUBLISHED 2023 · DOI: 10.1177/0976500X231189351

View on JPP original site ↗

ABSTRACT

Objectives: To investigate the allele and genotype frequencies of the warfarin-related genes VKORC1 (-1639G>A), CYP2C9*2, and CYP2C9*3 among healthy Saudis. Materials and Methods: This cross-sectional study involved 125 unrelated healthy Saudis ages 18–60 years visiting the King Abdulaziz University Hospital (KAUH) in Jeddah, Western Saudi Arabia. The Oragene™ DNA saliva collection kits were used to collect and extract DNA from saliva samples. A polymerase chain reaction-restriction fragment length polymorphism analysis was used to detect the mutant alleles. Results: Over 51.4% of the Saudi participants carried one or more mutant alleles. The frequency of the VKORC1 (-1639G>A) allele in Saudi was relatively high at 54.8%. The frequencies of the CYP2C9 allele were 19.6% and 54% for the CYP2C9*2 and CYP2C9*3 alleles, respectively, which are substantially more abundant than in other populations. Conclusion: The observed high frequencies of VKORC1 (-1639G>A) and CYP2C9*2 and CYP2C9*3 polymorphisms suggest that genetic testing should be considered before initiating warfarin therapy to predict the optimal initial dose of warfarin and minimize warfarin-related side effects.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Bagher, A. M., Alharbi, W. S., Gadi, L. S., Binmahfouz, L. S., & Hareeri, R. H. (2023). Allelic Variants in the Warfarin-related Genes VKORC1 and CYP2C9 in a Western Saudi Population. Journal of Pharmacology and Pharmacotherapeutics, 14(2), 125–132. https://doi.org/10.1177/0976500X231189351